Total IP	30
Total IP Rank #	47,845
IP Activity Score	2.2/5.0    21
IP Activity Rank #	38,898
Dominant Nice Class	Pharmaceutical, veterinary and s...

Patents Trademarks 13 2 2 3 7 2 1
Last Patent	2024 - Compositions and methods for tre...
First Patent	2006 - Bi-aryl meta-pyrimidine inhibito...
Last Trademark	2023 - INREBIC
First Trademark	2015 - INREBIC

Industry (Nice Classification)

Latest Inventions, Goods, Services 2024 Invention Compositions and methods for treating myelofibrosis. Provided herein are compositions and method... 2023 G/S Pharmaceutical and biological preparations for human use. G/S Pharmaceutical and biological preparations for human use. 2022 Invention Fedratinib for treating myeloproliferative disorders. The present disclosure provides methods of ... Invention Bet inhibitors as a treatment for myelofibrosis. The present disclosure provides methods, pharma... Invention Use of a bet inhibitor alone or in combination with fedratinib or ruxolitinib for treating a hema... 2021 Invention Methods of treating myeloproliferative disorders. The present disclosure provides methods of miti... Invention Methods of treating myeloproliferative disorders. The present disclosure provides methods of tre... Invention Dosing of fedratinib. The present disclosure provides methods of treating myeloproliferative dis... Invention Dosing of fedratinib. The present disclosure provides methods of treating myeloproliferative diso... G/S Pharmaceutical preparations for use in the treatment of myeloproliferative diseases, myelofibrosi... 2020 Invention Crystalline forms of a jak2 inhibitor. The present disclosure provides crystalline forms of a JA... Invention Crystalline forms of a jak2 inhibitor. The present disclosure provides crystalline forms of a JAK... 2019 Invention Methods of treating myeloproliferative disorders. The present disclosure provides methods of mit... Invention Methods of treating myeloproliferative disorders. The present disclosure provides methods of trea... G/S Pharmaceutical preparations for use in the treatment of myeloproliferative diseases, myelofibros... 2016 G/S Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodysplastic synd... 2015 G/S Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodsplatic syndr... G/S Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodsplatic syndro... 2013 Invention Compositions and methods for treating myelofibrosis. Provided herein are compositions and methods... 2010 Invention Bi-aryl meta-pyrimidine inhibitors of kinases. The invention provides biaryl meta-pyrimidine comp... 2008 Invention Use of bi-aryl meta-pyrimidine inhibitors of kinases. The invention provides biaryl meta-pyrimidi... Invention Use of bi-aryl meta-pyrimidine inhibitors of kinases. The invention provides methods of treating ...